Connect with us

Marijuana News

Estimated 2 million US teens are vaping marijuana, survey reports

CannaNews

Published

on

Estimated 2 million US teens are vaping marijuana, survey reports

A school-based survey shows nearly 1 in 11 U.S. students have used marijuana in electronic cigarettes, heightening health concerns about the new popularity of vaping among teens.

E-cigarettes typically contain nicotine, but many of the battery-powered devices can vaporize other substances, including marijuana. Results published Monday mean 2.1 million middle and high school students have used them to get high.

Vaping is generally considered less dangerous than smoking, because burning tobacco or marijuana generates chemicals that are harmful to lungs. But there is little research on e-cigarettes’ long-term effects, including whether they help smokers quit.

The rise in teenagers using e-cigarettes has alarmed health officials who worry kids will get addicted to nicotine, a stimulant, and be more likely to try cigarettes. Last week, the Food and Drug Administration gave the five largest e-cigarette makers 60 days to produce plans to stop underage use of their products.

Nearly 9 percent of students surveyed in 2016 said they used an e-cigarette device with marijuana, according to Monday’s report in the journal JAMA Pediatrics. That included one-third of those who ever used e-cigarettes.

The number is worrying “because cannabis use among youth can adversely affect learning and memory and may impair later academic achievement and education,” said lead researcher Katrina Trivers of the Centers for Disease Control and Prevention.

Students who said they lived with a tobacco user were more likely than others to report vaping marijuana.

It’s unclear whether marijuana vaping is increasing among teens or holding steady. The devices have grown into a multi-billion industry, but they are relatively new.

In states where marijuana is legal, shoppers can buy cartridges of liquid containing THC, the chemical in marijuana that gets people high, that work with a number of devices. Juul, by far the most popular e-cigarette device, does not offer marijuana pods, but users can re-fill cartridges with cannabis oil.

It was the first time a question about marijuana vaping was asked on this particular survey, which uses a nationally representative sample of students in public and private schools. More than 20,000 students took the survey in 2016.

A different survey from the University of Michigan in December found similar results when it asked for the first time about marijuana vaping. In that study, 8 percent of 10th graders said they vaped marijuana in the past year.

“The health risks of vaping reside not only in the vaping devices, but in the social environment that comes with it,” said University of Michigan researcher Richard Miech. Kids who vape are more likely to become known as drug users and make friends with drug users, he said, adding that “hanging out with drug users is a substantial risk factor for future drug use.”

Original Article at https://www.denverpost.com/2018/09/17/teens-vaping-marijuana/

Cannabis News

[Winner] November 1, 2018 Giveaway (Episode 2)

William Mottl

Published

on

Brady Shepherd wins our 2nd Rate.Review.Win! Giveaway!

hosted by Automatic Weapons

Continue Reading

Cannabis News

Automatic Weapons to host November CannaMaps Giveaway!

William Mottl

Published

on

Automatic Weapons | CannaMaps

Rate.Review.Win! Giveaway Meme for November 1, 2018 hosted by Automatic Weapons.

Rate and Review ANY Listing on CannaMaps for a chance to Win $200 Diamond CBD Gift Card. CannaMaps shirt and some stickers!

Look out for other cool prizes coming soon from Hydrofarm via INDOOR GARDENS

Automatic Weapons is a band from Cleveland, Ohio as our guest HOST for this months LIVE SHOW at 4:20pm on November 1, 2018

https://DiamondCBD.com

Giveaway

 

CannaMaps-Automatic-Weapons-Ad

Continue Reading

Marijuana News

Will mega marijuana deal get approval in New York?

CannaNews

Published

on

Will mega marijuana deal get approval in New York?

ALBANY — The planned merger of two of the nation’s largest cannabis companies is being closely watched by industry insiders in New York who are wondering just how state regulators are going to handle an acquisition that, on its face, seems to violate state law.

MedMen Enterprises and PharmaCann announced the $682 million deal to stockholders last week, noting that the acquisition would create the nation’s largest cannabis company with licenses to operate 79 facilities across a dozen states, including two cultivation facilities and eight medical marijuana dispensaries in New York.

The only catch?

New York Public Health Law, which allows marijuana for medical use only, prohibits a registered marijuana organization from owning and operating more than four dispensaries in the state. The provision was designed to prevent market domination, even as some argue it limits access for patients who must travel to far-flung destinations to get their medicine.

In response to that concern, the state last year doubled the number of medical marijuana organizations allowed to operate statewide from five to 10 — a move that also doubled the number of allowed dispensaries statewide from 20 to 40.

The four-dispensary-per-company limit remains, however.

MedMen, a Los Angeles-based company known for its high-end marijuana stores, would acquire the assets and licenses of Illinois-based PharmaCann in the stock deal, though it must gain regulatory approval from local and state authorities in each of the markets where those assets are held.

“We are in talks with the regulators in all of the jurisdictions impacted by this acquisition, including New York,” said MedMen spokesman Daniel Yi. “The first step in any acquisition is for the two parties to agree to the terms and enter into a binding contract. Then you go seek approvals from all the relevant regulators. We have begun that process now.”

New York’s Department of Health, which oversees the state’s still-nascent medical marijuana program, said Monday that any merger proposal submitted to the agency for approval must be in compliance with state law. There are also requirements regarding ownership changes, said department spokeswoman Jill Montag.

“Regulations prohibit a registered organization from changing the composition of its ownership without prior written approval of the Department of Health,” she said. “MedMen and PharmaCann do not have approval from the department to conduct this transaction, and at this time the department has insufficient information to determine if approval can be granted.”

MedMen said it expects the transaction to close within six months to a year. It declined to speculate on its plans should New York reject the deal.

“It would not be proper for us to get ahead of the process,” Yi said. “We are currently in talks with regulators and we feel confident about the outcomes.”

In a news release issued Monday, MedMen said that it will use “commercially reasonable efforts” to transition licenses to a third party if it is unable to gain regulatory approvals within a two-year time span, with proceeds going to the company and its investors.

Founded in 2014 in Oak Park, Ill., PharmaCann was one of the five original organizations registered to operate grow sites and retail stores in New York, which went live with its medical marijuana program in January 2016.

The firm quickly became a major player in the industry, and today is considered one of the nation’s leading providers of medical cannabis with operations in Illinois, New York, Maryland and Massachusetts, and planned expansions in Michigan, Ohio, Pennsylvania and Virginia.

Its facilities in New York include a cultivation center in Orange County and dispensaries in Albany, the Bronx, and Central and Western New York.

MedMen, meanwhile, had become a major player of its own, primarily out west, selling both recreational and medical marijuana. It entered the New York market last year when it bought out Bloomfield Industries, one of five original organizations licensed to operate in the state.

But it didn’t garner much attention until this past spring, when MedMen opened its first dispensary in Manhattan on pricey Fifth Avenue. The move appeared to be a gamble that New York would soon legalize recreational marijuana, since the state’s tightly regulated medical marijuana program is small by industry standards and unlikely to generate sizable revenues without significant expansion.

Indeed, New York appears poised to jump on the recreational bandwagon. Gov. Andrew M. Cuomo in January ordered a study into a regulated, adult-use program, and by June the Department of Health concluded such a program would have more positives than negatives.

A task force is currently researching and crafting legislation for consideration in the upcoming 2019 legislative session, and public hearings on the matter are being held statewide.

MedMen said Monday that it has consistently advocated for full legalization of marijuana, as well as an increase in the number of licenses and dispensaries.

“We believe that legal, regulated cannabis leads to safer, healthier and happier communities,” Yi said.

Original Article at https://www.timesunion.com/news/article/Will-mega-marijuana-deal-get-approval-in-New-York-13311377.php

Continue Reading

Trending